Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,676.61
(
-0.59%
)
US TECH 100
23,991.80
(
-0.58%
)
Dow Jones
46,589.02
(
-0.86%
)
Brent Oil
103.44
(
2.77%
)
Bitcoin
71,869.34
(
-2.80%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: jq1234 post# 129525

Wednesday, 10/26/2011 10:43:04 PM

Wednesday, October 26, 2011 10:43:04 PM

Post# of 257253

Well, it was thought JAK3 might have advantage over PFE's pan-JAK in safety



Of course INCY has argued precisely the opposite (given they have a JAK1/2) drug. But I assume they are talking their book.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today